Detection and Molecular Characterization of the SARS-CoV-2 Delta Variant and the Specific Immune Response in Companion Animals in Switzerland.

AY.129 AY.4 AY.43 B.1.617.2 Delta One Health SARS-CoV-2 animal next-generation sequencing phylogenetic analysis variant of concern variant specific antibodies viral adaptation

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
15 01 2023
Historique:
received: 20 12 2022
revised: 09 01 2023
accepted: 11 01 2023
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

In human beings, there are five reported variants of concern of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). However, in contrast to human beings, descriptions of infections of animals with specific variants are still rare. The aim of this study is to systematically investigate SARS-CoV-2 infections in companion animals in close contact with SARS-CoV-2-positive owners ("COVID-19 households") with a focus on the Delta variant. Samples, obtained from companion animals and their owners were analyzed using a real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) and next-generation sequencing (NGS). Animals were also tested for antibodies and neutralizing activity against SARS-CoV-2. Eleven cats and three dogs in nine COVID-19-positive households were RT-qPCR and/or serologically positive for the SARS-CoV-2 Delta variant. For seven animals, the genetic sequence could be determined. The animals were infected by one of the pangolin lineages B.1.617.2, AY.4, AY.43 and AY.129 and between zero and three single-nucleotide polymorphisms (SNPs) were detected between the viral genomes of animals and their owners, indicating within-household transmission between animal and owner and in multi-pet households also between the animals. NGS data identified SNPs that occur at a higher frequency in the viral sequences of companion animals than in viral sequences of humans, as well as SNPs, which were exclusively found in the animals investigated in the current study and not in their owners. In conclusion, our study is the first to describe the SARS-CoV-2 Delta variant transmission to animals in Switzerland and provides the first-ever description of Delta-variant pangolin lineages AY.129 and AY.4 in animals. Our results reinforce the need of a One Health approach in the monitoring of SARS-CoV-2 in animals.

Identifiants

pubmed: 36680285
pii: v15010245
doi: 10.3390/v15010245
pmc: PMC9864232
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MC_PC_19026
Pays : United Kingdom

Références

Nat Commun. 2020 Jul 8;11(1):3496
pubmed: 32641684
Emerg Microbes Infect. 2021 Dec;10(1):376-383
pubmed: 33317424
Front Vet Sci. 2022 Mar 01;9:790058
pubmed: 35310416
Viruses. 2021 Mar 23;13(3):
pubmed: 33806922
Proc Natl Acad Sci U S A. 2022 Feb 8;119(6):
pubmed: 35078920
Viruses. 2021 Oct 19;13(10):
pubmed: 34696534
Sci Transl Med. 2022 Nov 8;:eabn7979
pubmed: 36346321
BMC Vet Res. 2015 Nov 13;11:282
pubmed: 26566897
Front Vet Sci. 2021 Nov 10;8:779341
pubmed: 34901253
Viruses. 2021 May 19;13(5):
pubmed: 34069453
Emerg Infect Dis. 2020 Dec;26(12):3069-3071
pubmed: 32788033
Proc Natl Acad Sci U S A. 2021 Nov 23;118(47):
pubmed: 34732584
Viruses. 2021 Jul 15;13(7):
pubmed: 34372585
J Med Virol. 2020 Nov;92(11):2847-2851
pubmed: 32558947
J Infect. 2021 Oct;83(4):473-482
pubmed: 34332019
Viruses. 2021 Sep 12;13(9):
pubmed: 34578394
Viruses. 2021 Jul 26;13(8):
pubmed: 34452319
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24790-24793
pubmed: 32948692
Nature. 2020 Oct;586(7831):776-778
pubmed: 32408337
Microorganisms. 2022 Feb 02;10(2):
pubmed: 35208799
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Clin Infect Dis. 2021 Oct 5;73(7):e1870-e1877
pubmed: 32634826
Virol Sin. 2022 Apr;37(2):187-197
pubmed: 35279413
J Hosp Infect. 2021 Jan;107:98-100
pubmed: 32920017
Evol Med Public Health. 2022 Mar 29;10(1):142-155
pubmed: 35419205
Transbound Emerg Dis. 2022 Jul;69(4):e979-e991
pubmed: 34739748
Viruses. 2019 Oct 17;11(10):
pubmed: 31627345
N Engl J Med. 2020 Aug 6;383(6):592-594
pubmed: 32402157
Lancet Microbe. 2020 Sep;1(5):e218-e225
pubmed: 32838346
Zoonoses Public Health. 2022 Aug;69(5):587-592
pubmed: 35426241
Pathogens. 2021 Feb 23;10(2):
pubmed: 33672421
Infect Control Hosp Epidemiol. 2020 Sep;41(9):1110-1112
pubmed: 32297851
Proc Natl Acad Sci U S A. 2021 Nov 2;118(44):
pubmed: 34716263
Vet Microbiol. 2021 Sep;260:109179
pubmed: 34271305
Nat Biotechnol. 2020 Sep;38(9):1073-1078
pubmed: 32704169
MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):710-713
pubmed: 32525853
Nature. 2020 Jul;583(7818):834-838
pubmed: 32408338
Clin Transl Immunology. 2020 Jul 27;9(7):e1160
pubmed: 32742654
One Health. 2021 Dec;13:100295
pubmed: 34316508
BMC Vet Res. 2017 May 25;13(1):138
pubmed: 28545521
Clin Infect Dis. 2020 Nov 19;71(16):2230-2232
pubmed: 32266381
Res Vet Sci. 2021 Nov;140:229-232
pubmed: 34534904
PLoS Pathog. 2021 Feb 26;17(2):e1009373
pubmed: 33635912
Nature. 2020 Jul;583(7815):282-285
pubmed: 32218527
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Emerg Microbes Infect. 2020 Dec;9(1):2322-2332
pubmed: 33028154
Emerg Infect Dis. 2022 Jun;28(6):1154-1162
pubmed: 35608925
Vet Microbiol. 2006 Jan 10;112(1):11-21
pubmed: 16303261
Virus Evol. 2021 Jul 30;7(2):veab064
pubmed: 34527285
Nature. 2020 Dec;588(7836):E6
pubmed: 33199918
Transbound Emerg Dis. 2022 May;69(3):1656-1658
pubmed: 33955193
Cell Host Microbe. 2020 May 13;27(5):704-709.e2
pubmed: 32259477
J Infect Public Health. 2021 Sep;14(9):1201-1205
pubmed: 34416598
Viruses. 2022 Feb 17;14(2):
pubmed: 35216014
PLoS Pathog. 2022 Mar 21;18(3):e1010197
pubmed: 35312736
Vet Rec. 2021 Nov;189(9):e944
pubmed: 34738231
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Science. 2020 May 29;368(6494):1016-1020
pubmed: 32269068
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24614-24616
pubmed: 32958678
Virus Res. 2022 Mar;310:198673
pubmed: 34998863
Transbound Emerg Dis. 2021 Mar;68(2):973-976
pubmed: 32810370
Vet Med Sci. 2022 May;8(3):945-946
pubmed: 34958181
Mol Biol Evol. 2018 Feb 1;35(2):518-522
pubmed: 29077904
Transbound Emerg Dis. 2022 Sep;69(5):3001-3007
pubmed: 34080762
Bioinformatics. 2021 Jan 20;:
pubmed: 33471068
Viruses. 2022 Sep 14;14(9):
pubmed: 36146847
Vet Rec. 2021 Apr;188(8):e247
pubmed: 33890314
Bioinformatics. 2021 Dec 25;:
pubmed: 34954792
Transbound Emerg Dis. 2020 Nov;67(6):2324-2328
pubmed: 32500944
One Health. 2021 Jun;11:100192
pubmed: 33169106
PLoS Pathog. 2021 Dec 2;17(12):e1010022
pubmed: 34855916
Lancet Infect Dis. 2020 Nov;20(11):1263-1272
pubmed: 32679081
Proc Natl Acad Sci U S A. 2020 Oct 20;117(42):26382-26388
pubmed: 32994343
Viruses. 2019 Oct 29;11(11):
pubmed: 31671816
Viruses. 2021 Mar 17;13(3):
pubmed: 33802899
Viruses. 2021 Dec 16;13(12):
pubmed: 34960795
BMC Vet Res. 2021 Oct 7;17(1):322
pubmed: 34620166
Respir Res. 2020 Aug 27;21(1):224
pubmed: 32854739
Front Vet Sci. 2022 Apr 01;9:841430
pubmed: 35433922

Auteurs

Evelyn Kuhlmeier (E)

Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland.

Tatjana Chan (T)

Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland.

Cecilia Valenzuela Agüí (CV)

Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.
SIB Swiss Institute of Bioinformatics, 4058 Basel, Switzerland.

Barbara Willi (B)

Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland.

Aline Wolfensberger (A)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091 Zurich, Switzerland.

Christian Beisel (C)

Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.

Ivan Topolsky (I)

Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.
SIB Swiss Institute of Bioinformatics, 4058 Basel, Switzerland.

Niko Beerenwinkel (N)

Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.
SIB Swiss Institute of Bioinformatics, 4058 Basel, Switzerland.

Tanja Stadler (T)

Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.
SIB Swiss Institute of Bioinformatics, 4058 Basel, Switzerland.
Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.

Sarah Jones (S)

School of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Bearsden Road, Glasgow G61 1QH, UK.
MRC-University of Glasgow Centre for Virus, College of Medical, Veterinary and Life Sciences, University of Glasgow, Bearsden Road, Glasgow G61 1QH, UK.

Grace Tyson (G)

School of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Bearsden Road, Glasgow G61 1QH, UK.

Margaret J Hosie (MJ)

MRC-University of Glasgow Centre for Virus, College of Medical, Veterinary and Life Sciences, University of Glasgow, Bearsden Road, Glasgow G61 1QH, UK.

Katja Reitt (K)

Center for Laboratory Medicine, Veterinary Diagnostic Services, Frohbergstrasse 3, 9001 St. Gallen, Switzerland.

Julia Hüttl (J)

Center for Laboratory Medicine, Veterinary Diagnostic Services, Frohbergstrasse 3, 9001 St. Gallen, Switzerland.

Marina L Meli (ML)

Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland.

Regina Hofmann-Lehmann (R)

Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH